AE Wealth Management LLC Has $12.35 Million Holdings in Zoetis Inc. $ZTS

AE Wealth Management LLC lifted its stake in shares of Zoetis Inc. (NYSE:ZTS) by 26.7% in the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 84,364 shares of the company’s stock after buying an additional 17,786 shares during the period. AE Wealth Management LLC’s holdings in Zoetis were worth $12,345,000 at the end of the most recent quarter.

A number of other institutional investors also recently modified their holdings of ZTS. Brighton Jones LLC grew its holdings in Zoetis by 180.4% in the fourth quarter. Brighton Jones LLC now owns 4,629 shares of the company’s stock worth $754,000 after purchasing an additional 2,978 shares during the period. Empowered Funds LLC grew its stake in shares of Zoetis by 6.2% in the 1st quarter. Empowered Funds LLC now owns 11,293 shares of the company’s stock valued at $1,859,000 after buying an additional 657 shares during the period. Intech Investment Management LLC increased its position in Zoetis by 17.2% in the 1st quarter. Intech Investment Management LLC now owns 8,347 shares of the company’s stock valued at $1,374,000 after buying an additional 1,224 shares in the last quarter. Sivia Capital Partners LLC raised its stake in Zoetis by 73.8% during the 2nd quarter. Sivia Capital Partners LLC now owns 3,348 shares of the company’s stock worth $522,000 after buying an additional 1,422 shares during the period. Finally, Truist Financial Corp raised its stake in Zoetis by 18.5% during the 2nd quarter. Truist Financial Corp now owns 142,321 shares of the company’s stock worth $22,195,000 after buying an additional 22,247 shares during the period. Institutional investors and hedge funds own 92.80% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have commented on ZTS shares. Weiss Ratings cut Zoetis from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Wednesday. HSBC set a $140.00 price target on shares of Zoetis in a research report on Wednesday, December 10th. KeyCorp began coverage on shares of Zoetis in a report on Thursday, November 20th. They set a “sector weight” rating on the stock. Wall Street Zen upgraded shares of Zoetis from a “hold” rating to a “buy” rating in a report on Friday, January 23rd. Finally, JPMorgan Chase & Co. decreased their target price on shares of Zoetis from $230.00 to $200.00 and set an “overweight” rating for the company in a research report on Wednesday, November 5th. Five research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $152.45.

Zoetis Price Performance

ZTS opened at $124.79 on Friday. Zoetis Inc. has a 1 year low of $115.25 and a 1 year high of $177.40. The company has a debt-to-equity ratio of 1.31, a current ratio of 3.64 and a quick ratio of 2.28. The company has a market capitalization of $54.99 billion, a price-to-earnings ratio of 21.01, a P/E/G ratio of 2.10 and a beta of 0.97. The firm’s fifty day moving average price is $124.08 and its two-hundred day moving average price is $137.26.

Zoetis (NYSE:ZTS) last released its quarterly earnings results on Tuesday, November 4th. The company reported $1.70 earnings per share for the quarter, beating analysts’ consensus estimates of $1.62 by $0.08. Zoetis had a net margin of 28.21% and a return on equity of 57.19%. The company had revenue of $2.40 billion for the quarter, compared to analyst estimates of $2.42 billion. During the same period last year, the firm earned $1.58 earnings per share. The firm’s revenue was up .5% on a year-over-year basis. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. As a group, analysts anticipate that Zoetis Inc. will post 6.07 earnings per share for the current fiscal year.

Zoetis Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, March 3rd. Stockholders of record on Tuesday, January 20th will be paid a $0.53 dividend. This represents a $2.12 dividend on an annualized basis and a dividend yield of 1.7%. The ex-dividend date is Tuesday, January 20th. This is a boost from Zoetis’s previous quarterly dividend of $0.50. Zoetis’s dividend payout ratio (DPR) is presently 35.69%.

About Zoetis

Zoetis Inc (NYSE: ZTS) is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company’s offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.